TABLE 2

Tissue Distributions of Intraperitoneally and Intravenously Administered 186Re-MN-14 in Nude Mice Bearing Intraperitoneal LS174T Colon Cancer Xenografts

AdministrationOrganMean ± SD (n = 5) %ID/g at following hour after injection of radioconjugate:
24487296192
IntraperitonealTumor29.9 ± 7.377.8 ± 31.483.4 ± 18.566.0 ± 5.450.3 ± 29.2
Blood14.8 ± 1.012.7 ± 0.711.4 ± 0.88.9 ± 1.14.4 ± 2.7
Muscle1.24 ± 0.41.2 ± 0.11.2 ± 0.11.6 ± 1.40.5 ± 0.2
Lungs8.3 ± 1.27.0 ± 0.88.4 ± 1.56.6 ± 1.13.8 ± 2.2
Spleen3.8 ± 0.73.5 ± 0.43.2 ± 0.42.3 ± 0.51.6 ± 0.6
Kidneys4.3 ± 0.23.7 ± 0.23.4 ± 0.13.2 ± 0.41.7 ± 0.7
Liver5.2 ± 0.74.8 ± 0.34.6 ± 0.53.9 ± 0.52.0 ± 0.7
Intestine3.5 ± 0.81.8 ± 0.32.1 ± 0.41.5 ± 0.50.7 ± 0.3
Femur0.8 ± 0.11.1 ± 0.21.2 ± 0.20.7 ± 0.20.6 ± 0.2
IntravenousTumor58.1 ± 18.450.3 ± 21.168.2 ± 10.765.1 ± 14.267.8 ± 42.3
Blood12.8 ± 3.011.9 ± 1.3611.2 ± 1.110.6 ± 2.26.14 ± 1.9
Muscle0.9 ± 0.21.2 ± 0.11.0 ± 0.10.8 ± 0.10.7 ± 0.4
Lungs7.8 ± 2.410.5 ± 1.18.5 ± 0.89.6 ± 1.35.8 ± 1.8
Spleen3.8 ± 1.13.2 ± 0.32.8 ± 0.32.5 ± 0.21.9 ± 0.4
Kidneys3.8 ± 0.83.8 ± 0.33.3 ± 0.42.9 ± 0.31.5 ± 1.0
Liver5.4 ± 1.24.7 ± 0.34.5 ± 0.83.5 ± 0.51.6 ± 1.1
Intestine2.8 ± 0.92.2 ± 0.31.7 ± 0.11.4 ± 0.11.2 ± 0.2
Femur0.9 ± 0.40.8 ± 0.41.0 ± 0.20.5 ± 0.10.5 ± 0.1